|1.||Li, Jing: 8 articles (04/2008 - 08/2004)|
|2.||Geng, Meiyu: 5 articles (04/2006 - 08/2004)|
|3.||Hui, Bin: 3 articles (04/2008 - 04/2006)|
|4.||Miao, Benchun: 3 articles (12/2005 - 08/2004)|
|5.||Ding, Jian: 3 articles (07/2005 - 08/2004)|
|6.||Ai, Jing: 2 articles (05/2011 - 04/2006)|
|7.||Geng, Mei-yu: 2 articles (05/2011 - 04/2006)|
|8.||Xia, Wei: 2 articles (04/2006 - 01/2005)|
|9.||Xin, Xianliang: 2 articles (12/2005 - 01/2005)|
|10.||Fu, Xueyan: 2 articles (12/2005 - 07/2005)|
|1.||Acquired Immunodeficiency Syndrome (AIDS)
11/01/2007 - "Herein, we report that sulfated polymannuroguluronate (SPMG), a novel anti-AIDS drug candidate now undergoing phase II clinical trial, significantly eliminated Tat-induced angiogenesis in SLK cells both in vitro and in vivo. "
05/01/2011 - "Sulfated polymannuroguluronate (SPMG), a candidate anti-AIDS drug, inhibited HIV replication and interfered with HIV entry into host T lymphocytes. "
12/01/2005 - "Sulfated polymannuroguluronate (SPMG) has entered the phase II clinical trial as the first anti-AIDS drug candidate in China. "
12/01/2005 - "Sulfated polymannuroguluronate, a novel anti-AIDS drug candidate, inhibits T cell apoptosis by combating oxidative damage of mitochondria."
07/01/2005 - "Sulfated polymannuroguluronate (SPMG) has entered the Phase II clinical trial as the first anti-acquired immune deficiency syndrome (AIDS) drug candidate in China. "
|2.||Kaposi Sarcoma (Kaposi's Sarcoma)
04/01/2006 - "We herein report that sulfated polymannuroguluronate (SPMG), a novel anti-acquired immunodeficiency syndrome drug candidate now in a phase II clinical trial, significantly reversed Tat-induced release of pro-inflammatory cytokines [tumour necrosis factor (TNF)-alpha, interleukin (IL)-1beta) and IL-6] and dose dependently decreased the accumulation of reactive oxygen species and nitric oxide in THP-1 cells. "
|2.||tat Gene Products (tat Protein)
|3.||Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
|4.||Human Immunodeficiency Virus tat Gene Products
|5.||Reactive Oxygen Species (Oxygen Radicals)
|6.||Trans-Activators (Trans-Acting Factor)
|7.||Nitric Oxide (Nitrogen Monoxide)